BeOne Medicines AG Stock
Stocks
ONC
US07725L1026
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 322.42 USD | +1.17% |
|
+3.85% | +6.40% |
| 07-15 | Beone Medicines Insider Sold Shares Worth $18,256,808, According to a Recent SEC Filing | MT |
| 07-15 | Beone Medicines Insider Sold Shares Worth $44,626,424, According to a Recent SEC Filing | MT |
| Market Cap | 35.43B 31.05B 28.77B 26.48B 49.94B 3,412B 50.54B 343B 134B 1,672B 133B 130B 5,774B | P/E 2026 * |
48.1x | P/E 2027 * | 32.2x |
|---|---|---|---|---|---|
| Enterprise Value | 31.41B 27.53B 25.51B 23.48B 44.27B 3,025B 44.8B 304B 119B 1,482B 118B 115B 5,118B | EV / Sales 2026 * |
4.84x | EV / Sales 2027 * | 4.1x |
| Free-Float |
0.74% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: BeOne Medicines AG
| 1 day | +1.12% | ||
| 1 week | +3.85% | ||
| Current month | +13.43% | ||
| 1 month | +18.93% | ||
| 3 months | +3.47% | ||
| 6 months | -4.60% | ||
| Current year | +6.40% |
| 1 week | 303.08 |  | 328 |
| 1 month | 269.52 | | 328 |
| Current year | 253.95 | | 372.73 |
| 1 year | 253.95 | | 385.22 |
| 3 years | 126.97 | | 385.22 |
| 5 years | 118.18 | | 426.56 |
| 10 years | 24.53 | | 426.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Oyler
CEO | Chief Executive Officer | 57 | 28/10/2010 |
Aaron Rosenberg
DFI | Director of Finance/CFO | 50 | 22/07/2024 |
Xiao Bin Wu
PSD | President | 64 | 01/04/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
John Oyler
CHM | Chairman | 57 | 27/01/2016 |
Xiao Dong Wang
CHM | Chairman | 62 | 28/10/2010 |
Anthony Hooper
BRD | Director/Board Member | 71 | 01/01/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 17/7/26 | Other | Chief Executive Officer | -840,164 | 0.0589% | ||
| 17/7/26 | Other | Chief Executive Officer | 969,420 | 0.0680% | ||
| 16/7/26 | Other | Chief Executive Officer | -2,165,761 | 0.1518% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.17% | +3.85% | +9.35% | +65.56% | 35.43B | |
| -4.89% | -7.74% | -3.35% | +10.48% | 48.5B | |
| +0.52% | +0.16% | +382.70% | +612.14% | 38.97B | |
| -0.36% | -2.81% | +7.27% | -11.90% | 33.65B | |
| -0.87% | -1.56% | -1.43% | +29.16% | 26.58B | |
| -0.97% | -5.54% | - | - | 16.82B | |
| +0.23% | +1.13% | +12.03% | +116.73% | 15.18B | |
| +1.32% | +1.85% | +11.40% | +15.33% | 13.89B | |
| +0.28% | -2.63% | +3.75% | -30.94% | 12.76B | |
| -1.79% | -3.67% | +1,196.63% | +557.18% | 11.56B | |
| Average | -0.52% | -1.19% | +179.82% | +151.53% | 25.33B | |
| Weighted average by Cap. | -0.85% | -1.27% | +124.75% | +148.35% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.49B 5.68B 5.27B 4.85B 9.14B 625B 9.25B 62.86B 24.6B 306B 24.35B 23.82B 1,057B | 7.44B 6.52B 6.04B 5.56B 10.49B 717B 10.62B 72.13B 28.23B 351B 27.93B 27.33B 1,213B |
| Net income | 738M 646M 599M 551M 1.04B 71.03B 1.05B 7.15B 2.8B 34.81B 2.77B 2.71B 120B | 1.11B 970M 899M 827M 1.56B 107B 1.58B 10.72B 4.2B 52.22B 4.15B 4.06B 180B |
| Net Debt | -4.02B -3.53B -3.27B -3.01B -5.67B -387B -5.74B -38.99B -15.26B -190B -15.1B -14.78B -656B | -4.94B -4.33B -4.01B -3.69B -6.96B -475B -7.04B -47.83B -18.72B -233B -18.53B -18.13B -804B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/07/26 | US$323.16 | +1.40% | 237,730 |
| 21/07/26 | US$318.69 | +2.61% | 536,209 |
| 20/07/26 | US$310.58 | -0.46% | 343,927 |
| 17/07/26 | US$312.02 | -1.70% | 428,134 |
| 16/07/26 | US$317.42 | +1.98% | 594,848 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ONC Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition